Il Dong Pharmaceutical Co., Ltd. (249420) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Il Dong Pharmaceutical Co., Ltd. (249420:KRX), powered by AI.

Current Price
₩12,590
P/E Ratio
13.4
Market Cap
398.3B
Sector
Healthcare
What is the Il Dong Pharmaceutical Co., Ltd. stock price forecast?

Il Dong Pharmaceutical Co., Ltd. is currently trading at ₩12,590. View real-time AI analysis on Alpha Lenz.

What is Il Dong Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Il Dong Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Il Dong Pharmaceutical Co., Ltd.'s P/E ratio?

Il Dong Pharmaceutical Co., Ltd.'s P/E ratio is 13.4.

Il Dong Pharmaceutical Co., Ltd.

KRX · 249420
₩12,590+440(+3.62%)Market closedKRX regular session 09:00–15:30 KST
Ask about Il Dong Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Il Dong Pharmaceutical Co., Ltd. trades at a P/E of 13.4 (undervalued) with solid ROE of 13.6%.

Ask for details

Company Overview

Il Dong Pharmaceutical Co., Ltd. is a leading company in the pharmaceutical industry, dedicated to developing, manufacturing, and distributing a diverse range of healthcare products. Primarily engaged in the production of pharmaceutical drugs, Il Dong focuses on the R&D of innovative treatments that address a broad spectrum of health conditions. The company's product portfolio includes prescription medications, over-the-counter drugs, and health supplements, catering to various medical fields such as cardiology, neurology, and gastroenterology. Il Dong Pharmaceutical plays a significant role in the healthcare sector by providing high-quality medicines and collaborating with healthcare professionals to enhance patient care. With a robust distribution network, the company ensures that its products are accessible to hospitals, clinics, and pharmacies, both domestically and internationally, thereby contributing substantially to the global pharmaceutical market.

CEO윤웅섭
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,067

Company Statistics

FY 2025

Profile

₩398,325,592,680Market Cap
₩566,933,738,490Revenue
31.64MShares Out
1,067Employees

Margins

38.76%Gross
7.85%EBITDA
3.44%Operating
5.60%Pre-Tax
4.18%Net

Valuation

13.37P/E
1.50P/B
0.65EV/Sales
9.94EV/EBITDA
228.05P/FCF

Growth (CAGR)

-3.85%Rev 3Yr
0.18%Rev 5Yr
N/AOp Inc 3Yr
24.07%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

4.08%ROA
13.59%ROE
7.56%ROIC

Financial Health

₩64,845,229,060Cash & Cash Equivalents
₩268,671,835,170Net Debt
139.25%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Il Dong Pharmaceutical Co., Ltd. (ticker: 249420) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,067 employees. Market cap is $398.3B.

The current price is ₩12,590 with a P/E ratio of 13.37x and P/B of 1.5x.

ROE is 13.59% and operating margin is 3.44%. Annual revenue is $566.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Il Dong Pharmaceutical Co., Ltd. (249420) Stock Forecast 2026 ₩12,590 — Price, Financials & Analyst Targets | Alpha Lenz